{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:27:53Z","timestamp":1791412073957,"version":"4.3.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T00:00:00Z","timestamp":1482278400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ankara T\u0131pl\u0131lar Vakf\u0131"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00296-016-3639-4","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T19:18:02Z","timestamp":1482347882000},"page":"593-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Anti-angiotensin II type 1 receptor autoantibodies (AT1R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6443-6426","authenticated-orcid":false,"given":"Ufuk","family":"\u0130lgen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fc\u00e7teba Enes","family":"Yayla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur\u015fen","family":"D\u00fczg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,21]]},"reference":[{"issue":"4","key":"3639_CR1","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.4049\/jimmunol.138.4.1164","volume":"138","author":"PO Couraud","year":"1987","unstructured":"Couraud PO (1987) Anti-angiotensin II anti-idiotypic antibodies bind to angiotensin II receptor. J Immunol 138(4):1164\u20131168","journal-title":"J Immunol"},{"issue":"7","key":"3639_CR2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00004872-200018070-00017","volume":"18","author":"ML Fu","year":"2000","unstructured":"Fu ML, Herlitz H, Schulze W, Wallukat G, Micke P, Eftekhari P, Sjogren KG, Hjalmarson A, Muller-Esterl W, Hoebeke J (2000) Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens 18(7):945\u2013953","journal-title":"J Hypertens"},{"issue":"5","key":"3639_CR3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1586\/eci.11.56","volume":"7","author":"Y Xia","year":"2011","unstructured":"Xia Y, Kellems RE (2011) Receptor-activating autoantibodies and disease: preeclampsia and beyond. Expert Rev Clin Immunol 7(5):659\u2013674","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"3639_CR4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","volume":"352","author":"D Dragun","year":"2005","unstructured":"Dragun D, Muller DN, Brasen JH, Fritsche L, Nieminen-Kelha M, Dechend R, Kintscher U, Rudolph B, Hoebeke J, Eckert D et al (2005) Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352(6):558\u2013569","journal-title":"N Engl J Med"},{"issue":"10","key":"3639_CR5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/tri.12371","volume":"27","author":"M Banasik","year":"2014","unstructured":"Banasik M, Boratynska M, Koscielska-Kasprzak K, Kaminska D, Bartoszek D, Zabinska M, Myszka M, Zmonarski S, Protasiewicz M, Nowakowska B et al (2014) The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes. Transpl Int 27(10):1029\u20131038","journal-title":"Transpl Int"},{"issue":"8","key":"3639_CR6","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.transproceed.2014.09.029","volume":"46","author":"M Banasik","year":"2014","unstructured":"Banasik M, Boratynska M, Koscielska-Kasprzak K, Kaminska D, Zmonarski S, Mazanowska O, Krajewska M, Bartoszek D, Zabinska M, Myszka M et al (2014) Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss. Transplant Proc 46(8):2618\u20132621","journal-title":"Transplant Proc"},{"issue":"7","key":"3639_CR7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/nep.12441","volume":"20","author":"A Fuss","year":"2015","unstructured":"Fuss A, Hope CM, Deayton S, Bennett GD, Holdsworth R, Carroll RP, Coates PT (2015) C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies. Nephrol (Carlton) 20(7):467\u2013473","journal-title":"Nephrol (Carlton)"},{"key":"3639_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv375","author":"J Lee","year":"2015","unstructured":"Lee J, Huh KH, Park Y, Park BG, Yang J, Jeong JC, Lee J, Park JB, Cho JH, Lee S et al. (2015) The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation. Nephrol Dial Transpl. doi: 10.1093\/ndt\/gfv375","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"3639_CR9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.transproceed.2014.11.055","volume":"47","author":"J Lee","year":"2015","unstructured":"Lee J, Park Y, Kim BS, Lee JG, Kim HJ, Kim YS, Huh KH (2015) Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation. Transplant Proc 47(3):649\u2013652","journal-title":"Transplant Proc"},{"issue":"10","key":"3639_CR10","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","volume":"13","author":"M Taniguchi","year":"2013","unstructured":"Taniguchi M, Rebellato LM, Cai J, Hopfield J, Briley KP, Haisch CE, Catrou PG, Bolin P, Parker K, Kendrick WT et al (2013) Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies. Am J Transplant 13(10):2577\u20132589","journal-title":"Am J Transplant"},{"issue":"12","key":"3639_CR11","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0b013e3181fd97f1","volume":"90","author":"NL Reinsmoen","year":"2010","unstructured":"Reinsmoen NL, Lai CH, Heidecke H, Haas M, Cao K, Ong G, Naim M, Wang Q, Mirocha J, Kahwaji J et al (2010) Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients. Transplantation 90(12):1473\u20131477","journal-title":"Transplantation"},{"issue":"10","key":"3639_CR12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/TP.0000000000000185","volume":"98","author":"H Ohe","year":"2014","unstructured":"Ohe H, Uchida Y, Yoshizawa A, Hirao H, Taniguchi M, Maruya E, Yurugi K, Hishida R, Maekawa T, Uemoto S et al (2014) Association of anti-human leukocyte antigen and anti-angiotensin II type 1 receptor antibodies with liver allograft fibrosis after immunosuppression withdrawal. Transplantation 98(10):1105\u20131111","journal-title":"Transplantation"},{"issue":"4","key":"3639_CR13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/TP.0000000000000182","volume":"98","author":"A Chiron","year":"2014","unstructured":"Chiron A, Bouaziz JD, Carmagnat M, Peffault de Latour R, Lafaurie-Bergeron A, Robin M, Xhaard A, Toubert A, Charron D, Guigue N et al (2014) Anti-Angiotensin type 1 receptor antibodies in chronic graft-versus-host disease. Transplantation 98(4):470\u2013474","journal-title":"Transplantation"},{"issue":"1","key":"3639_CR14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcf.2014.07.007","volume":"14","author":"K Budding","year":"2015","unstructured":"Budding K, van de Graaf EA, Hoefnagel T, Kwakkel-van Erp JM, van Kessel DA, Dragun D, Hack CE, Otten HG (2015) Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis. J Cyst Fibros 14(1):42\u201345","journal-title":"J Cyst Fibros"},{"issue":"7","key":"3639_CR15","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","volume":"190","author":"MO Becker","year":"2014","unstructured":"Becker MO, Kill A, Kutsche M, Guenther J, Rose A, Tabeling C, Witzenrath M, Kuhl AA, Heidecke H, Ghofrani HA et al (2014) Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis. Am J Respir Crit Care Med 190(7):808\u2013817","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3639_CR16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","volume":"70","author":"G Riemekasten","year":"2011","unstructured":"Riemekasten G, Philippe A, Nather M, Slowinski T, Muller DN, Heidecke H, Matucci-Cerinic M, Czirjak L, Lukitsch I, Becker M et al (2011) Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis 70(3):530\u2013536","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3639_CR17","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","volume":"16","author":"A Kill","year":"2014","unstructured":"Kill A, Tabeling C, Undeutsch R, Kuhl AA, Gunther J, Radic M, Becker MO, Heidecke H, Worm M, Witzenrath M et al (2014) Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis. Arthritis Res Ther 16(1):R29","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"3639_CR18","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 65(11):2737\u20132747","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3639_CR19","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202\u2013205","journal-title":"J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3639-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-016-3639-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3639-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T10:27:33Z","timestamp":1718965653000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-016-3639-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,21]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["3639"],"URL":"https:\/\/doi.org\/10.1007\/s00296-016-3639-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,21]]}}}